Eikon Therapeutics, Inc. (EIKN)

NASDAQ: EIKN · Real-Time Price · USD

9.66

-1.05 (-9.77%)

At close: Apr 24, 2026, 4:00 PM EDT

9.40

-0.25 (-2.64%)

After-hours: Apr 24, 2026, 7:30 PM EDT

Eikon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	104.9	129.18	112.78
Short-Term Investments	231.07	90.93	317.63
Cash & Short-Term Investments	335.98	220.11	430.41
Cash Growth	52.64%	-48.86%	-
Other Current Assets	12.94	7.78	6.01
Total Current Assets	348.92	227.89	436.43
Net Property, Plant & Equipment	233.86	259.13	86.88
Other Long-Term Assets	11.95	4.22	2.4
Total Assets	594.73	491.24	525.71
Accounts Payable	0.68	17.58	2.19
Accrued Expenses	44.3	29.56	24.21
Current Portion of Leases	10.03	9.31	5.05
Total Current Liabilities	55.01	56.45	31.44
Long-Term Leases	247.29	193.15	26.69
Other Long-Term Liabilities	10	5.35	0.73
Total Long-Term Liabilities	257.29	198.5	27.42
Total Liabilities	312.3	254.95	58.86
Common Stock	-	-	0
Additional Paid-in Capital	41.48	33.01	19.75
Retained Earnings	-920.51	-604.94	-361.13
Total Common Shareholders' Equity	-879.03	-571.93	-341.37
Minority Interest	1,161	808.22	808.22
Shareholders' Equity	282.44	236.29	466.85
Total Liabilities & Equity	594.73	491.24	525.71
Total Debt	257.32	202.46	31.74
Net Cash (Debt)	78.66	17.65	398.68
Net Cash Growth	345.59%	-95.57%	-
Net Cash Per Share	27.18	7.01	196.70
Book Value	-879.03	-571.93	-341.37
Book Value Per Share	-303.75	-226.99	-168.43
Tangible Book Value	-879.03	-571.93	-341.37
Tangible Book Value Per Share	-303.75	-226.99	-168.43

Updated Jan 9, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q